Article | October 31, 2018

Replacing The TQT With Exposure-QT Response Study

Source: Medpace

Proarrhythmic Potential For Nonantiarrhythmic Drugs, which introduced the concept of the Through QT (TQT), study was recently revised to include the opportunity to demonstrate the cardiac safety of a new drug by utilizing Exposure-QT response study data in dose escalation and other studies. This now gives sponsors a choice between TQT and Exposure-QT studies.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader